Portfolio
ARETO LABS
Areto Labs is a technology company specializing in creating tools to enhance online community engagement and reduce toxicity in digital spaces. Their primary focus is on developing AI-driven software that monitors and moderates online interactions to foster a healthier and more inclusive online environment. The core of Areto Labs' innovation lies in their advanced AI-driven technology for real-time monitoring and moderation of online interactions.
RL CORE
Traditionally, industrial control systems have been constrained by fixed control parameters established at their inception, leading to excessive energy usage, high maintenance costs, and suboptimal operational performance. RL Core revolutionizes this approach by leveraging a data-driven AI approach called reinforcement learning to allow for control settings to be dynamically and continuously refined in real-time. The result is massive cost and energy savings for control system operators, small and large, with applications in water treatment, irrigation, and beyond.
NANOSTICS
Nanostics is working to provide a diagnostic test for prostate cancer that is non-invasive and provides early detection. The Innovation Fund invested and is supporting further fundraise with investors in the USA and Canada, with introductions to NHS and top oncologists in the UK. The Founder John Lewis is Professor at University of Alberta, Bird Dogs Chair of Translational Oncology and serial international entrepreneur.
PULSE MEDICA
Pulse Medica has the goal of improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease. The Innovation Fund invested and is assisting with introductions to customers and other investors. Notable board members include VMS Threshold Impact founder and investor Ray Muzyka and Chen Fong, a global health thought leader based in Alberta. This investment is in partnership with UCeed (University of Calgary fund).